Kim Kelderman

Insider Reports History

Location
Minneapolis, MN
Signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kim Kelderman:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIO-TECHNE Corp Chief Executive Officer, Director Stock Options (Right to Buy) 90,441 $5,031,232 $55.63 03 Nov 2025 Direct
BIO-TECHNE Corp Chief Executive Officer, Director Performance Restricted Stock Units 70,708 $3,933,486 $55.63 03 Nov 2025 Direct
BIO-TECHNE Corp Chief Executive Officer, Director Common Stock 48,665 $3,044,969 $62.57 03 Nov 2025 Direct
BIO-TECHNE Corp Chief Executive Officer, Director Restricted Stock Units 35,354 $1,966,743 $55.63 03 Nov 2025 Direct
BIO-TECHNE Corp Chief Executive Officer, Director Performance Stock Options (Right to Buy) 25,945 $1,443,320 $55.63 03 Nov 2025 Direct
BIO-TECHNE Corp Chief Executive Officer, Director Stock Option (Right to Buy) 25,944 $1,443,264 $55.63 03 Nov 2025 Direct
CONMED Corp Director Common Stock 0 $0 $52.48 08 Sep 2025 Direct
CONMED Corp Director Options To Purchase Common Stock 6,227 08 Sep 2025 Direct
CONMED Corp Director RSUs (Restricted Stock Units) 500 08 Sep 2025 Direct

Insider Reports Filed by Kim Kelderman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TECH BIO-TECHNE Corp 03 Nov 2025 1 -$144,098 4 Chief Executive Officer, Director 05 Nov 2025, 16:46
CNMD CONMED Corp 08 Sep 2025 2 $0 4 Director 09 Sep 2025, 16:13
CNMD CONMED Corp 08 Sep 2025 0 $0 3 Director 09 Sep 2025, 13:12
TECH BIO-TECHNE Corp 15 Aug 2025 6 -$230,748 4 Chief Executive Officer, Director 19 Aug 2025, 17:28
TECH BIO-TECHNE Corp 22 Jul 2025 3 -$182,992 4 Chief Executive Officer, Director 24 Jul 2025, 16:26
TECH BIO-TECHNE Corp 15 Jul 2025 3 -$91,683 4 Chief Executive Officer, Director 17 Jul 2025, 17:04
TECH BIO-TECHNE Corp 27 Jan 2025 4 -$530,135 4 Chief Executive Officer, Director 29 Jan 2025, 16:35
TECH BIO-TECHNE Corp 01 Nov 2024 1 -$183,003 4 Chief Executive Officer, Director 05 Nov 2024, 16:47
TECH BIO-TECHNE Corp 29 Aug 2024 2 $99,919 4 Chief Executive Officer, Director 03 Sep 2024, 16:05
TECH BIO-TECHNE Corp 15 Aug 2024 3 $0 4 Chief Executive Officer, Director 19 Aug 2024, 17:29
TECH BIO-TECHNE Corp 31 Jul 2024 3 -$249,193 4 Chief Executive Officer, Director 02 Aug 2024, 16:17
TECH BIO-TECHNE Corp 01 Nov 2023 3 $0 4 Chief Operating Officer 05 Feb 2024, 18:33
TECH BIO-TECHNE Corp 01 Nov 2023 2 $0 4 Chief Operating Officer 03 Nov 2023, 18:34
TECH BIO-TECHNE Corp 24 Aug 2023 2 $99,960 4 Pres. Diagnostics & Genom 28 Aug 2023, 16:19
TECH BIO-TECHNE Corp 15 Aug 2023 2 $0 4/A Pres. Diagnostics & Genom 14 Dec 2023, 18:13
TECH BIO-TECHNE Corp 05 Aug 2023 3 -$340,101 4 Pres. Diagnostics & Genom 08 Aug 2023, 17:28
TECH BIO-TECHNE Corp 23 Aug 2022 2 $99,967 4 Pres. Diagnostics & Genom 25 Aug 2022, 17:38
TECH BIO-TECHNE Corp 15 Aug 2022 3 $0 4 PRES. DIAGNOSTICS & GENOM 17 Aug 2022, 17:25
TECH BIO-TECHNE Corp 07 Aug 2022 3 -$464,925 4 Pres. Diagnostics & Genom 09 Aug 2022, 19:00
TECH BIO-TECHNE Corp 08 Feb 2022 2 $299,901 4 Pres. Diagnostics & Genom 10 Feb 2022, 15:31
TECH BIO-TECHNE Corp 19 Nov 2021 4 -$177,299 4 Pres. Diagnostics & Genom 23 Nov 2021, 19:02
TECH BIO-TECHNE Corp 22 Sep 2021 1 -$434,870 4 Pres. Diagnostics & Genom 24 Sep 2021, 16:30
TECH BIO-TECHNE Corp 06 Aug 2021 6 -$418,701 4 Pres. Diagnostics & Genom 10 Aug 2021, 18:21
TECH BIO-TECHNE Corp 09 Jun 2021 1 -$351,163 4 Pres. Diagnostics & Genom 11 Jun 2021, 16:59
TECH BIO-TECHNE Corp 25 May 2021 1 -$358,280 4 Pres. Diagnostics & Genom 27 May 2021, 16:26